|
Market Closed -
NYSE
21:00:02 02/07/2026 BST
|
5-day change
|
1st Jan Change
|
|
230.69 USD
|
+0.70%
|
 |
+6.92%
|
+15.65%
|
|
07-03 |
Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
|
PR
| |
07-01 |
Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing
|
MT
| |
07-01 |
Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating
|
MT
| |
06-18 |
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
|
BU
| |
06-18 |
Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating
|
MT
| |
06-17 |
Charles River Laboratories Shares Rise After Morgan Stanley Upgrade
|
MT
| |
06-17 |
Morgan Stanley Upgrades Charles River Laboratories International to Overweight From Equal Weight, Adjusts PT to $220 From $185
|
MT
| |
06-05 |
Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says
|
MT
| |
06-03 |
Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09:55 AM
| | |
06-02 |
Charles River Laboratories International, Inc. Presents at 46th Annual William Blair Growth Stock Conference, Jun-02-2026 10:00 AM
| | |
06-01 |
Charles River Laboratories to Present at William Blair and Jefferies Conferences
|
BU
| |
05-13 |
Charles River Laboratories, Medipost Sign MoU on GMP-Compliant Testing
|
MT
| |
05-13 |
Charles River Laboratories and Medipost sign non-exclusive MoU to advance GMP testing solutions
|
RE
| |
05-13 |
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions
|
BU
| |
05-11 |
Charles River Laboratories International, Inc. Approves Ratification of PricewaterhouseCoopers LLP as Independent Auditors
|
CI
| |
05-11 |
Charles River Laboratories International, Inc. Announces Board Elections
|
CI
| |
05-11 |
Charles River Laboratories International, Inc. Accelerates Digital Pathology with Ai-Powered End-To-End Workflow
|
CI
| |
05-11 |
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow
|
BU
| |
05-08 |
Charles River Laboratories International, Inc. Seeks M&A Opportunities
|
CI
| |
05-08 |
Charles River Laboratories International : Quarterly Report for Quarter Ending March 28, 2026 (Form 10-Q)
|
PU
| |
05-07 |
Tranche Update on Charles River Laboratories International, Inc.'s Equity Buyback Plan announced on November 5, 2025.
|
CI
| |
05-07 |
Charles River Laboratories International, Inc., Q1 2026 Earnings Call, May 07, 2026
| | |
05-07 |
Charles River Laboratories International, Inc. Reports Earnings Results for the First Quarter Ended March 28, 2026
|
CI
| |
05-07 |
Charles River Laboratories Q1 Adjusted Earnings Decline, Revenue Rises; Maintains 2026 Earnings Guidance
|
MT
| |
05-07 |
(CRL) Charles River Laboratories International Expects 2026 Non-GAAP EPS Range $10.80 - $11.30, vs. FactSet Est of $11.08
|
MT
|
No results match your criteria Select your edition All financial news and data tailored to specific country editions | 
